Application note: From our platforms to your pen injector
Posted: 29 June 2021 | Nemera | No comments yet
Nemera offers four product platforms for pen development and manufacturing. These include reusable and disposable devices which are designed for various therapies to meet key users’ needs.
Parenteral administration has several significant advantages such as better bioavailability, faster onset of effect, more predictable pharmacokinetic and pharmacodynamic profiles and avoiding the first-pass effect.